GreenLight (532nm) LASER (XPS) Enucleation vs. Thulium LASER Enucleation of Prostate for Treatment of Benign Prostatic Hyperplasia

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this study the investigators aim to test TGreenlight (532-nm) laser Photoselective Enucleation of the Prostate (Green LEP) using (XPS) 180W system ) vs Thulium Laser 200 W Enucleation of the Prostate (ThuLEP) in reduction of lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) in a randomized controlled trial. Furthermore, all peri-operative parameters, urinary flow parameters, prostate size changes and complications associated with the procedures will be compared.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 40
Maximum Age: 80
Healthy Volunteers: f
View:

• Patients' age ≥ 40 years

• LUTS secondary to BOO due to BPH who failed medical treatment

• International prostate symptom scores (IPSS) \>15 and bother score (QOL) ≥ 3 (according to IPSS question 8)

• Peak urinary flow rate (Qmax) \<15 ml/sec with at least 125 ml voided volume or Patients with acute urine retention secondary to BPH who failed trial of voiding on medical treatment.

• ASA (American society of anaesthesiologists) score ≤3.

• TRUS prostate size \> /= 80 ml

Locations
Other Locations
Egypt
Urology and Nephrology Center
RECRUITING
Al Mansurah
Contact Information
Primary
Mahmoud Nabil Laymon, MD
dr_mahmoudlaymon@yahoo.com
00201002275698
Backup
Adel M Nabeeh, Professor
adel_nabeeh51@hotmail.com
0020100196665
Time Frame
Start Date: 2017-04-01
Estimated Completion Date: 2024-11-01
Participants
Target number of participants: 110
Treatments
Experimental: ThuLEP
Thulium laser enucleation of prostate
Experimental: Green LEP
Greenlight laser enucleation of prostate
Related Therapeutic Areas
Sponsors
Leads: Mansoura University

This content was sourced from clinicaltrials.gov